We created a drug candidate, CRMA-1001, that silences the hepatitis B virus using methylation tags without cutting its DNA.
Nigerian firm Ash Biomedical produces seven diagnostic products for HIV, malaria, hepatitis and pregnancy, expanding access to locally made testing solutions.